Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy

por Grossi, F, Rijavec, E, Genova, C, Barletta, G, Biello, F, Maggioni, C, Burrafato, G, Sini, C, Dal Bello, M G, Meyer, K, Roder, J, Roder, H, Grigorieva, J
Publicado 2017

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

por Dal Bello, M. G., Filiberti, R. A., Alama, A., Orengo, A. M., Mussap, M., Coco, S., Vanni, I., Boccardo, S., Rijavec, E., Genova, C., Biello, F., Barletta, G., Rossi, G., Tagliamento, M., Maggioni, C., Grossi, F.
Publicado 2019

Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature

por Boutros, A., Bottini, A., Rossi, G., Tanda, E.T., Spagnolo, F., Barletta, G., Croce, E., Fava, P., Parisi, A., De Rosa, F., Palla, M., Marconcini, R., Ferrari, M., Grandis, M., Spallarossa, P., Sarocchi, M., Arboscello, E., Del Mastro, L., Lambertini, M., Pronzato, P., Genova, C.
Publicado 2023